Tenofovir Disoproxil Emtricitabine Efavirenz Viatris 300/200/600 — tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30

Medicine package · Australian Government Department of Health, Disability and Ageing · Australia

  • PBS item code 11732L
  • PBS listing item 11732L_23128_1353_47939_55248

What the source publishes

Active ingredients
tenofovir disoproxil + emtricitabine + efavirenz
Form
Tablet containing tenofovir disoproxil maleate 300 mg with emtricitabine 200 mg and efavirenz 600 mg
Package
tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30
Administrative status
PBS-listed

Names this record is found by

Complete source data
au:pbs:items:11732L_23128_1353_47939_55248
{
  "form": "Tablet containing tenofovir disoproxil maleate 300 mg with emtricitabine 200 mg and efavirenz 600 mg",
  "name": "Tenofovir Disoproxil Emtricitabine Efavirenz Viatris 300/200/600 — tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30",
  "brand": "Tenofovir Disoproxil Emtricitabine Efavirenz Viatris 300/200/600",
  "route": "Oral",
  "pbsCode": "11732L",
  "liItemId": "11732L_23128_1353_47939_55248",
  "marketed": null,
  "packSize": 30,
  "supplier": "Alphapharm Pty Ltd",
  "useDomain": "unknown",
  "supplyOnly": false,
  "genericName": "tenofovir disoproxil + emtricitabine + efavirenz",
  "programCode": "CA",
  "presentation": "tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30",
  "scheduleCode": "4753",
  "sourceStatus": null,
  "supplyRegime": null,
  "firstListedOn": "2023-02-01",
  "legalDrugName": "Tenofovir with emtricitabine and efavirenz",
  "listingStatus": "PBS-listed",
  "targetSpecies": [],
  "nonEffectiveOn": null,
  "organisationId": "142",
  "supplyOnlyFrom": null,
  "benefitTypeCode": "S",
  "supplyOnlyUntil": null,
  "copyrightNotices": [
    "Copyright (c) 2024 Department of Health, Commonwealth of Australia",
    "Permission is granted to use and redistribute this content, as long as all copyright statements are retained. Permission is not granted to modify this content.",
    "For further copyright information of this content, please refer to: https://www.health.gov.au/using-our-websites/copyright"
  ],
  "manufacturerCode": "AL",
  "scheduleRevision": 2,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "au.pbs.items"
  },
  "patientEligibility": "not-assessed",
  "scheduleEffectiveOn": "2026-11-01",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "extemporaneousIngredient": false
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=au" \
  --data-urlencode "sourceId=au.pbs.items" \
  --data-urlencode "id=au:pbs:items:11732L_23128_1353_47939_55248"